| NCT06509841 | The Impact of Jiaji Electroacupuncture and Scalp Electroacupuncture on Traumatic Spinal Cord Injury | Hangzhou Medical College | | - Age All ages
- Level C1-S5
AIS - All
| Ended | 84 | NA | Psychosocial/other | General health | - American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
| 5 months | 01 May 2024 | 19 July 2024 | 1 | |
| NCT06583395 | Quest to Analyze One Thousand Humans Meditating | VitaMed Research LLC | | - Age ≥ 21 yrs
- Level C1-S5
AIS - All
| By invitation | 3000 | | | General health | - Blood Pressure and Heart Rate Regulation
| 4 years | 05 December 2021 | 04 September 2024 | 1 | |
| NCT03077204 | BIO4 Clinical Case Study: Cervical Spine | Seton Healthcare Family | | - Age ≥ 19 yrs
- Level C1-S5
AIS - All
| Ended | 20 | PHASE4 | Surgery | General health | - Pain Visual Analog Scale (VAS)
| 1 year | 06 April 2017 | 10 March 2017 | 1 | |
| NCT06612112 | Trunk Balance and Functional Independence in Individuals With SCI | Afyonkarahisar Health Sciences University | | - Age ≥ 18 yrs
- Level T1-T12
AIS - ≥ 6 months
- NOT have intracardiac defibrillators
| Ended | 32 | | | Arm/hand function | - Modified Functional Reach Test (mFRT)
- Spinal Cord Independence Measure (SCIM)
- Wheelchair Skills Test (WST, 4.1)
| 0 days | 01 September 2024 | 25 September 2024 | 2 | |
| NCT06532760 | Identification of Sodium Channel Fragments as Serum Biomarkers of a Traumatic Central Nervous System Injury | Assistance Publique Hopitaux De Marseille | | - Age 18 - 75 yrs
- Level C4-T12
AIS A, B, C, D- ≤ 6 null
- NOT have another neurological or mental disorder or neurodegenerative disease
| Recruiting soon | 40 | NA | | Spasticity | | 6 months | 01 October 2024 | 01 August 2024 | 0 | |
| NCT06596291 | Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization | EG 427 | | - Age 18 - 75 yrs
- Level C1-L5
AIS A, B, C, D, E- All
| Recruiting | 16 | PHASE1, PHASE2 | Drug | Bladder health/function | - Adverse Events (AEs)
- Bowel and bladder control
- Urodynamic examination
| 1 year | 08 January 2025 | 19 September 2024 | 5 | |
